GreaterGood News
A Memory Doctor Explains Why Normal Testing Does Not End Every Conversation
Subjective cognitive decline: what to do when memory feels different despite normal tests, steps for early detection and prevention.
A Memory Doctor Explains Why Normal Testing Does Not End Every Conversation
Subjective cognitive decline: what to do when memory feels different despite normal tests, steps for early detection and prevention.
An Alzheimer’s Diagnosis at 46 Brought Answers About a Rare Inherited Mutation
Francisco Rios' experience reveals living with a PSEN1 gene mutation and early-onset Alzheimer's while pursuing clinical trials and care.
An Alzheimer’s Diagnosis at 46 Brought Answers About a Rare Inherited Mutation
Francisco Rios' experience reveals living with a PSEN1 gene mutation and early-onset Alzheimer's while pursuing clinical trials and care.
Familiar Music Can Help Families Find Connection When Dementia Makes Words Hard
Music therapy for dementia can spark connection, comfort and joy, improving daily care and quality of life.
Familiar Music Can Help Families Find Connection When Dementia Makes Words Hard
Music therapy for dementia can spark connection, comfort and joy, improving daily care and quality of life.
She Found a Breast Lump at 26 With No Known Family History
Andrea's case shows young-onset breast cancer can occur without family history; new breast lumps deserve prompt evaluation.
She Found a Breast Lump at 26 With No Known Family History
Andrea's case shows young-onset breast cancer can occur without family history; new breast lumps deserve prompt evaluation.
Octavia Spencer Shares How a Routine Physical Revealed Her Diabetes
Octavia Spencer urges testing and lifestyle changes, highlighting the uACR test to protect kidney health.
Octavia Spencer Shares How a Routine Physical Revealed Her Diabetes
Octavia Spencer urges testing and lifestyle changes, highlighting the uACR test to protect kidney health.
Tirzepatide Approved to Reduce Cardiovascular Risk in People With Type 2 Diabetes
FDA approval of tirzepatide to reduce cardiovascular risk in type 2 diabetes offers a new organ-protective treatment option.
Tirzepatide Approved to Reduce Cardiovascular Risk in People With Type 2 Diabetes
FDA approval of tirzepatide to reduce cardiovascular risk in type 2 diabetes offers a new organ-protective treatment option.